SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-076045
Filing Date
2022-03-15
Accepted
2022-03-15 16:16:06
Documents
13
Period of Report
2022-03-11
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d305831d8k.htm   iXBRL 8-K 28242
2 EX-10.1 d305831dex101.htm EX-10.1 147812
  Complete submission text file 0001193125-22-076045.txt   319224

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20220311.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20220311_lab.xml EX-101.LAB 19502
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20220311_pre.xml EX-101.PRE 12162
7 EXTRACTED XBRL INSTANCE DOCUMENT d305831d8k_htm.xml XML 3589
Mailing Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121
Business Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39512 | Film No.: 22741284
SIC: 2834 Pharmaceutical Preparations